The five-year relative survival rate (people alive five years after their diagnosis) for people with HCC is 21%. But many factors contribute to life expectancy, including how advanced HCC is, …

2015年5月18日 · The prognosis of hepatocellular carcinoma depends on both tumor burden and liver dysfunction. Tumor-node-metastasis (TNM) does not account for the degree of …

Available therapeutic options for HCC are dictated by the complex interplay of tumor stage and the extent of underlying liver disease. This topic review will provide an overview of staging and …

2024年9月24日 · The major outcomes explored in this study were (1) survival probability stratified by study era, BCLC stage at time of diagnosis, and treatment group and (2) 5-year hazard …

Even if sorafenib and regorafenib are applied in HCC, the overall outcome of HCC remains unsatisfactory with the median survival in early and advanced HCC of about 6-9 months and 1 …

2021年1月21日 · The prognosis for HCC is driven by the tumour stage, with curative options providing a 5-year survival exceeding 70% for early-stage HCC compared with a median …

2021年10月29日 · Our results indicate a significant improvement in survival for HCC patients from 1988 to 2015, which may be attributable to advances in early diagnosis and therapeutic …

With high rates of recurrence post-treatment, hepatocellular carcinoma (HCC) is one of the most common types of cancer worldwide and the major cause of cancer death. To improve the …

4 天之前 · Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The prognostic significance of the neutrophil-to-lymphocyte ratio (NLR) in …

2025年3月19日 · Hepatocellular carcinoma (HCC) is an aggressive liver malignancy and the third leading cause of cancer-related mortality worldwide [].In China, liver cancer ranks fourth in …